Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania.
Eglė Sakalauskaitė-JuodeikienėGiedrė ArmalienėRasa KizlaitienėLoreta BagdonaitėNataša GiedraitienėDalia MickevičienėDaiva RastenytėGintaras KaubrysDalius JatuzisPublished in: Brain and behavior (2018)
AQP4-Ab test was positive for one-tenth of patients with CNS inflammatory demyelinating diseases other than typical MS in our study. AQP4-Ab testing is highly recommended for patients presenting with not only TM and ON but also an atypical course of MS and ADEM.